search
Back to results

Validity of a Supersimplified Device for Diagnosis of Patients With Suspected Obstructive Sleep Apnoea-hypopnoea (OSAH)

Primary Purpose

Obstructive Sleep Apnea

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
PSG
MicroMESAM system
Sponsored by
Basque Health Service
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Obstructive Sleep Apnea focused on measuring Sleep apnoea, Diagnosis, Blood pressure, Body mass index, Breath analysis

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients 18 to 75 years of both sexes.
  2. clinical suspicion of OSAH defined as subjects with breathing pauses during sleep and / or asphyxiated sounds, with or without excessive daytime sleepiness as measured by the Epworth scale and who have asked for a sleep test to rule out OSAH.
  3. Informed consent signed by the patient.

Exclusion Criteria:

  1. Place of residence more than 100 km from the hospital.
  2. inability to perform psychophysical study at home.
  3. cardio-vascular disease, cerebro-vascular or respiratory or acute severe unstable as to preclude the proper conduct of studies at home and / or PSG in the laboratory.
  4. Patients with chronic insomnia or recognize sleep less than six hours.
  5. Patients with depression (both point 4 and 5 are the potential causes of false negatives in a PR for lack of sufficient sleep time).
  6. nasal obstruction complete or nearly complete, which prevents obtaining a quality signal with MicroMESAM

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    MicroMESAM

    PSG

    Arm Description

    Sleep study made by MicroMESAM system

    Sleep study made by PSG (polysomnography)

    Outcomes

    Primary Outcome Measures

    Number of patients correctly diagnosed by MicroMESAM (APNEA-LINK)

    Secondary Outcome Measures

    Full Information

    First Posted
    April 18, 2011
    Last Updated
    February 6, 2013
    Sponsor
    Basque Health Service
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01347398
    Brief Title
    Validity of a Supersimplified Device for Diagnosis of Patients With Suspected Obstructive Sleep Apnoea-hypopnoea (OSAH)
    Official Title
    Validity of a Supersimplified Device for Diagnosis of Patients With Suspected Obstructive Sleep Apnoea-hypopnoea (OSAH).
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2013
    Overall Recruitment Status
    Unknown status
    Study Start Date
    March 2009 (undefined)
    Primary Completion Date
    December 2013 (Anticipated)
    Study Completion Date
    April 2014 (Anticipated)

    3. Sponsor/Collaborators

    Name of the Sponsor
    Basque Health Service

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The diagnosis of OSASH requires expensive sleep tests that generate long waiting lists, so we need simplified and rapid diagnostic tools. The ApneaLinkTM, is a device that allows the assessment of respiratory events by measuring the flow ventilation with a nasal cannula connected to a pressure transducer.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Obstructive Sleep Apnea
    Keywords
    Sleep apnoea, Diagnosis, Blood pressure, Body mass index, Breath analysis

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    815 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    MicroMESAM
    Arm Type
    Experimental
    Arm Description
    Sleep study made by MicroMESAM system
    Arm Title
    PSG
    Arm Type
    Active Comparator
    Arm Description
    Sleep study made by PSG (polysomnography)
    Intervention Type
    Procedure
    Intervention Name(s)
    PSG
    Intervention Description
    Sleep study made by PSG (polysomnography)
    Intervention Type
    Procedure
    Intervention Name(s)
    MicroMESAM system
    Intervention Description
    Sleep study made by MicroMESAM system
    Primary Outcome Measure Information:
    Title
    Number of patients correctly diagnosed by MicroMESAM (APNEA-LINK)
    Time Frame
    3 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    75 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients 18 to 75 years of both sexes. clinical suspicion of OSAH defined as subjects with breathing pauses during sleep and / or asphyxiated sounds, with or without excessive daytime sleepiness as measured by the Epworth scale and who have asked for a sleep test to rule out OSAH. Informed consent signed by the patient. Exclusion Criteria: Place of residence more than 100 km from the hospital. inability to perform psychophysical study at home. cardio-vascular disease, cerebro-vascular or respiratory or acute severe unstable as to preclude the proper conduct of studies at home and / or PSG in the laboratory. Patients with chronic insomnia or recognize sleep less than six hours. Patients with depression (both point 4 and 5 are the potential causes of false negatives in a PR for lack of sufficient sleep time). nasal obstruction complete or nearly complete, which prevents obtaining a quality signal with MicroMESAM

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    25325508
    Citation
    Masa JF, Duran-Cantolla J, Capote F, Cabello M, Abad J, Garcia-Rio F, Ferrer A, Fortuna AM, Gonzalez-Mangado N, de la Pena M, Aizpuru F, Barbe F, Montserrat JM; Spanish Sleep Network. Efficacy of home single-channel nasal pressure for recommending continuous positive airway pressure treatment in sleep apnea. Sleep. 2015 Jan 1;38(1):13-21. doi: 10.5665/sleep.4316.
    Results Reference
    derived
    PubMed Identifier
    25325484
    Citation
    Masa JF, Duran-Cantolla J, Capote F, Cabello M, Abad J, Garcia-Rio F, Ferrer A, Mayos M, Gonzalez-Mangado N, de la Pena M, Aizpuru F, Barbe F, Montserrat JM; Spanish Sleep Network; Larrateguy LD, de Castro JR, Garcia-Ledesma E, Utrabo I, Corral J, Martinez-Null C, Egea C, Cancelo L, Garcia-Diaz E, Carmona-Bernal C, Sanchez-Armengol A, Fortuna AM, Miralda RM, Troncoso MF, Monica G, Martinez-Martinez M, Cantalejo O, Pierola J, Vigil L, Embid C, Del Mar Centelles M, Prieto TR, Rojo B, Vanesa L. Effectiveness of home single-channel nasal pressure for sleep apnea diagnosis. Sleep. 2014 Dec 1;37(12):1953-61. doi: 10.5665/sleep.4248.
    Results Reference
    derived

    Learn more about this trial

    Validity of a Supersimplified Device for Diagnosis of Patients With Suspected Obstructive Sleep Apnoea-hypopnoea (OSAH)

    We'll reach out to this number within 24 hrs